The search for effective disease-modifying treatments for neurodegenerative conditions remains one of the most pressing challenges in contemporary biomedicine. Among these, Alzheimer’s disease (AD) stands out as a devastating progressive disorder characterized by massive synaptic loss, neuroinflammation, protein aggregation, and the steady deterioration of cognitive faculties. While conventional pharmaceutical approaches largely focus on temporary symptom […]